CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Nuclear Medicine Equipment Market Report by Product (Single-Photon Emission Computed Tomography, Positron Emission Tomography, Planar Scintigraphy), Application (Neurology, Oncology, Cardiology, and Others), End User (Hospitals, Imaging Centers, Academic and Research Institutes, and Others), and Region 2024-2032
... 2024-2032 The global nuclear medicine equipment market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% ... Read More
-
Tardive Dyskinesia Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine
... This report on global tardive dyskinesia market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global tardive dyskinesia ... Read More
-
Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035
... period 2024-2035. The focus of blood-brain barrier drugs and technologies is to address the challenges posed by the selective nature of the blood-brain barrier, enabling therapeutic agents to reach the brain directly. Recent years have ... Read More
-
Psychiatry - 2024 U.S. Market Research Report with Updated Analysis & Forecasts
... with over 100+ data sets covering 2015-2028. This Kentley Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns by product lines, size of company, concentration segmentation, business ... Read More
-
Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2024(Status and Outlook)
... disease that causes nerve cells to gradually break down and die. The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half ... Read More
-
Global Telemental Health Market
... (Providers, Payers, Patients) And By Geography – Covid-19 Impact Analysis, Post Covid Analysis, Opportunities, Trends And Forecast From 2020 to 2032The global Telemental Health market was valued at $21.43 Billion in 2023 and is anticipated ... Read More
-
Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034
... 1,467 million which is further expected to increase by 2034. In 2023, the total diagnosed prevalence of MCI in Parkinson’s disease was highest in Germany among the EU4 and the UK, accounting for nearly 223 ... Read More
-
Brain Health Supplements Market
... 6.29 billion in 2024 to USD 11.55 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period of 2024-2032. Pandemic had a very good impact on the market through encouraging people to speak ... Read More
-
Regenerative Medicine Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology (Stem Cell Therapy, Gene Therapy, Tissue Engineering, Cellular Therapy); Application (Orthopedics, Cardiovascular, Neurology, Dermatology, Oncology); and End-User (Hospitals and Clinics, Research Institutions, Pharmaceutical and Biotechnology Companies, Others)
... and End-User (Hospitals and Clinics, Research Institutions, Pharmaceutical and Biotechnology Companies, Others) Report Overview: The "Global Regenerative Medicine Market Analysis and Forecast" report offers a comprehensive examination of the regenerative medicine market from 2020 to ... Read More
-
Global Precision Medicine Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Delirium - Global Clinical Trials Review, 2024
... the clinical trials on Delirium. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Social Anxiety Disorder (SAD/Social Phobia) - Global Clinical Trials Review, 2024
... Phobia) Clinical trials scenario. This report provides top line data relating to the clinical trials on Social Anxiety Disorder (SAD/Social Phobia). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Precision Neurodegenerative Disease Market, Global, 2024–2028
... symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarkers. Precision NDD has changed clinical trial design, ... Read More
-
Global Nuclear Medicine Market Size study, by Type (Diagnostics, Therapeutics), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Regional Forecasts 2022-2032
... at approximately USD 8.94 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 19.4% over the forecast period 2024-2032. Nuclear medicine encompasses a range of pharmaceutical drugs containing ... Read More
-
Digital Mental Health Market Research Report Information by Component (Software [Cloud-based and Web-based] and Services [Cognitive Behavioral Therapy, Acceptance and Commitment Therapy (ACT), and Other Services]), by Disorder Type (Mental Disorder [Anxiety Disorder, Post-Traumatic Stress, Substance Abuse Disorder, Schizophrenia, and Other Mental Disorder] and Behavioral Disorder [Attention Deficit Hyperactivity Disorder (ADHD), Emotional Behavioral Disorder, Oppositional Defiant Disorder, Obsessive Compulsive Disorder (OCD), and Other Behavioral Disorder]), by Age Group (Children & Adolescents (10 to 19), Adult (20 to 65), and Geriatric (Above 65)), by End User (Patients, Payers, and Providers) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032
... Military Small Boats} ), By Size (<=20 Feet, >20 Feet), and By Seating Capacity (<=6 passengers, >6 passengers), By Horse Power(<=150 HP,>300 HP,150-300 HP), By Material (Aluminum, Fiberglass, HDPE, Other Materials (PVC)), By Country (Australia, ... Read More
-
Global Cell and Gene Therapy Market Size Study, by Therapy Type (Cell Therapy, Gene Therapy), by Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders, Others) and Regional Forecasts 2022-2032
... and Gene Therapy Market was valued at approximately USD 12.62 billion in 2023 and exhibiting a compound annual growth rate (CAGR) of 18.04% during the forecast period 2024-2032. Cell and gene therapy are advanced medical ... Read More
-
Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global dementia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dementia ... Read More
-
Migraine: 68-Market Analysis and Sales Forecast
... including widely used triptans and ergot alkaloids used in abortive treatment amongst others as well as oral preventive therapies such as antidepressants, anticonvulsants, and beta blockers and the newer CGRP-targeting mAbs or gepants across the ... Read More
-
Mental Health Clinical Trials Market Size & Share Analysis - Growth, Trends and Forecasts (2024 - 2029)
... to reach USD 4.77 billion by 2029, growing at a CAGR of 8% during the forecast period (2024-2029). The key factors driving the growth of the mental health clinical trials market are the increasing prevalence ... Read More
-
Global Traumatic Brain Injury Assessment and Management Devices Market 2024-2028
... 1707.8 mn during 2023-2028, accelerating at a CAGR of 8.09% during the forecast period. The report on the traumatic brain injury assessment and management devices market provides a holistic analysis, market size and forecast, trends, ... Read More
-
Global Addictions Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Migraine: Seven-Market Drug Forecast and Market Analysis
... the value of the migraine market in the 7MM in 2023 was $9.2 billion. This market is defined as sales of acute and preventatitve treatments including widely used triptans and ergot alkaloids used in abortive ... Read More
-
AI-assisted Radiology Market Research Report Information by Technique (X-rays, Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography (PET), and Others), by Application (Neurology, Mammography (Breast Cancer), Cardiovascular, Respiratory and Pulmonary, Orthopedics, and Others), by End User (Hospitals, Diagnostic Imaging Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World – Industry Forecast till 2032
... User (Hospitals, Diagnostic Imaging Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World – Industry Forecast till 2032 The market for AI-assisted radiology was estimated to be worth USD ... Read More
-
Brain Health Supplements Market Report by Product (Natural Molecules, Herbal Extract, Vitamins and Minerals), Form (Tablets and Capsules, Powder, and Others), Distribution Channel (Supermarkets and Hypermarkets, Drug Stores, Online Stores, and Others), Application (Memory Enhancement, Attention and Focus, Depression and Mood, Sleep and Recovery, Anti-aging and Longevity, and Others), and Region 2024-2032
... Attention and Focus, Depression and Mood, Sleep and Recovery, Anti-aging and Longevity, and Others), and Region 2024-2032 The global brain health supplements market size reached US$ 6.2 Billion in 2023. Looking forward, IMARC Group expects ... Read More
Research Assistance
